244 related articles for article (PubMed ID: 36135715)
1. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
Front Immunol; 2022; 13():941351. PubMed ID: 35958590
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A meta-analysis.
Huang Z; Xie N; Liu H; Wan Y; Zhu Y; Zhang M; Tao Y; Zhou H; Liu X; Hou J; Wang C
J Oral Pathol Med; 2019 Oct; 48(9):788-798. PubMed ID: 31323145
[TBL] [Abstract][Full Text] [Related]
6. Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis.
de Ruiter EJ; Bisheshar SK; de Roest RH; Wesseling FWR; Hoebers FJP; van den Hout MFCM; Leemans CR; Brakenhoff RH; de Bree R; Terhaard CHJ; Willems SM
Virchows Arch; 2022 Aug; 481(2):223-231. PubMed ID: 35451620
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
8. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
9. CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm.
Yao S; Huang Z; Wei C; Wang Y; Xiao H; Chen S; Huang Z
BMC Oral Health; 2023 Jun; 23(1):411. PubMed ID: 37344840
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
[TBL] [Abstract][Full Text] [Related]
11. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
[TBL] [Abstract][Full Text] [Related]
12. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
Ma SR; Liu JF; Jia R; Deng WW; Jia J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study.
John S; Joseph AP; Raghavan Pillai VB; Ramani P; P J; Ramalingam K
Cureus; 2024 Mar; 16(3):e56323. PubMed ID: 38628992
[TBL] [Abstract][Full Text] [Related]
15. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
[TBL] [Abstract][Full Text] [Related]
16. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
Xiao T; Lin F; Zhou J; Tang Z
Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
[TBL] [Abstract][Full Text] [Related]
17. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic genes in oral squamous cell carcinoma microenvironment.
Zhu L; Zhang X; Chen Y; Yan D; Han J
Cancer Biomark; 2022; 34(4):523-532. PubMed ID: 35275524
[TBL] [Abstract][Full Text] [Related]
19. Epithelial PD-L1 expression at tumor front predicts overall survival in a cohort of oral squamous cell carcinomas from Sudan.
Gaafar NM; Osman TA; Elsheikh M; Ahmed IA; Dongre H; Fromreide S; Suleiman AM; Johannessen AC; Nginamau ES; Costea DE
Clin Exp Dent Res; 2022 Dec; 8(6):1467-1477. PubMed ID: 36177667
[TBL] [Abstract][Full Text] [Related]
20. A2b and A3 adenosine receptors may act as promotive and prognostic factors in oral squamous cell carcinoma.
Zeng L; Wang C; Wang Z; Xiong H; Zhang T; Chen W; Hu X; Su T
J Craniomaxillofac Surg; 2023; 51(7-8):508-515. PubMed ID: 37596174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
